9 results
-
List item
Human medicine European public assessment report (EPAR): Zinplava
Bezlotoxumab, Enterocolitis, Pseudomembranous
Date of authorisation: 18/01/2017, Revision: 9, Authorised, Last updated: 14/03/2023 -
List item
Human medicine European public assessment report (EPAR): Raptiva
efalizumab, Psoriasis
Date of authorisation: 20/09/2004, Revision: 8, Withdrawn, Last updated: 04/08/2009 -
List item
Orphan designation: Fumagillin for: Treatment of diarrhoea associated with intestinal microsporidial infection
Date of designation: 05/02/2002, Withdrawn, Last updated: 10/08/2016Fumagillina Trattamento della diarrea associata ad infezione intestinale … Fumagilina Tratamiento de diarrea asociada a la infección … -
List item
Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use'
Last updated: 12/09/2022 -
List item
Public data from Article 57 database
Last updated: 17/10/2022 -
List item
National expert: Emilia Cercenado Mansilla, The Spanish Agency Of Medicines And Medical Devices (updated)
- Declaration of interests - 41.48 KB | PDF
- Curriculum Vitae - 468.19 KB | PDF
-
List item
Joint EMEA(NRG)/EFPIA Workshop on Invented Names
London, 11/09/2006, Last updated: 01/09/2006 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 4-8 July 2016
European Medicines Agency, London, UK, from 04/07/2016 to 08/07/2016, Last updated: 04/07/2016 -
List item
PRAC: meeting archive 2015-2017
Last updated: 13/05/2016